Brevican, neurocan, tenascin-C and versican are mainly responsible for the invasiveness of low-grade astrocytoma.
about
Extracellular matrix macromolecules: potential tools and targets in cancer gene therapyContributions of chondroitin sulfate proteoglycans to neurodevelopment, injury, and cancer.Relevance of IGFBP2 proteolysis in glioma and contribution of the extracellular protease ADAMTS1Microsomal membrane proteome of low grade diffuse astrocytomas: Differentially expressed proteins and candidate surveillance biomarkers.Biological functions of iduronic acid in chondroitin/dermatan sulfate.Chondroitin sulfate proteoglycans potently inhibit invasion and serve as a central organizer of the brain tumor microenvironment.Therapeutic targeting of hyaluronan in the tumor stroma.Sugar glues for broken neuronsTumor Grade versus Expression of Invasion-Related Molecules in Astrocytoma.The Unwanted Cell Migration in the Brain: Glioma Metastasis.Molecular machineries of pH dysregulation in tumor microenvironment: potential targets for cancer therapyNeurocan, an extracellular chondroitin sulfate proteoglycan, stimulates neuroblastoma cells to promote malignant phenotypes.Tenascin-C and fibronectin expression divide early stage tongue cancer into low- and high-risk groups.Effect of Concomitant Radiochemotherapy on Invasion Potential of Glioblastoma.
P2860
Q26996081-241B37A2-9E0F-4746-AE7F-B1FCB6748E40Q34005886-131DA5F6-7E92-42FB-913A-3A4046C6ECEFQ34100940-EED91708-CCD5-446C-9561-5A8C48AEF14BQ36953938-8A8E1769-ADE8-4514-AB5E-78F96FC2372FQ37029047-D411AE31-5C6F-44AC-B8FA-79F495341686Q37196329-20176789-FDF9-47F3-B028-DB7A6EE79D53Q38161392-3F95A523-4A75-4CC5-926D-811ED58AA587Q38256971-36D576AB-78B1-436C-84A0-420AB6ADB5BFQ38761444-F60FE5C1-4403-4E90-8FC6-7891B0B7FB47Q39288566-ADA8C2BE-0CF6-4859-A115-0156F9ABBE74Q41109846-76D13B11-C505-4729-9A13-77A60D2FBD05Q47136770-96EB5874-5CF2-4FB9-B0DA-4113A7A8420CQ50218828-9F2BE7FA-4068-4ECB-BB57-AE066DB413B5Q52148219-1874FB86-04F6-4971-8DAF-78E15128803D
P2860
Brevican, neurocan, tenascin-C and versican are mainly responsible for the invasiveness of low-grade astrocytoma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Brevican, neurocan, tenascin-C ...... ness of low-grade astrocytoma.
@en
Brevican, neurocan, tenascin-C ...... ness of low-grade astrocytoma.
@nl
type
label
Brevican, neurocan, tenascin-C ...... ness of low-grade astrocytoma.
@en
Brevican, neurocan, tenascin-C ...... ness of low-grade astrocytoma.
@nl
prefLabel
Brevican, neurocan, tenascin-C ...... ness of low-grade astrocytoma.
@en
Brevican, neurocan, tenascin-C ...... ness of low-grade astrocytoma.
@nl
P2093
P2860
P1476
Brevican, neurocan, tenascin-C ...... ness of low-grade astrocytoma.
@en
P2093
Almos Klekner
Annamária Kenyeres
Csaba D Szemcsák
Gábor Hutóczki
Gábor Zahuczky
Imre Varga
Judit Tóth
László Bognár
Zoltán Hanzély
Zsolt Adamecz
P2860
P2888
P304
P356
10.1007/S12253-011-9461-0
P577
2011-10-14T00:00:00Z